Vizibl and Sanofi have entered into a Phase I partnership to streamline processes around supplier management.
Software-as-a-service (SaaS) platform provider, Vizibl, has announced, in a Sept. 16, 2020 press release, the formation of a Phase I partnership with Sanofi to streamline processes around supplier management.
The partnership will see Sanofi’s key supplier management teams use Vizibl’s Supplier Collaboration and Innovation (SC&I) solution to build more strategic relationships with top tier suppliers. Additionally, Sanofi will use Vizibl to capture continuous improvement and innovation opportunities from suppliers as a part of its supplier nurture program.
“In today’s hyper-dynamic environment, Vizibl enables Sanofi to bring transparency to its supplier relationships and optimize its strategic versus run-the-business activities to make better investment decisions and deliver outstanding growth and value opportunities,” said Mark Perera, CEO at Vizibl, in the press release. “We look forward to changing the world together with Sanofi and cannot wait to see the great results that come out of this relationship for Sanofi’s customers.”
Source: Vizibl
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
INTERPHEX 2025: Use of Walk-In Chambers for Bio/Pharma Development and Manufacturing
April 2nd 2025Sitting down with the PharmTech Group at INTERPHEX 2025, Christopher Murphy, director of Global Business Development and Service Customer Support at Environmental Specialties, discusses the design and critical role of walk-in chambers in the bio/pharmaceutical industry.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.